Institutional Ownership Takeda Pharmaceutical CO LTD (TAK)
This table provides information about the institutional ownership of Takeda Pharmaceutical CO LTD (TAK). We have compiled data on the 370 institutions that hold shares in the stock, with a total of 73.1 Million shares, which have been reported (via 13F filing form) to have a value of $1.1 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
Jul 28, 2025 Q2 2025 |
3,910
shares
|
$58,884
0.0% of portfolio
|
Q2 2025
Added 39.69%
|
|
|
Erste Asset Management Gmb H
Vienna, C4 |
Aug 14, 2025 Q2 2025 |
3,674
shares
|
$55,330
0.0% of portfolio
|
Q4 2022
Closed
|
|
|
Northwestern Mutual Wealth Management CO
|
Aug 13, 2025 Q2 2025 |
3,586
shares
|
$54,005
0.0% of portfolio
|
Q2 2025
Added 56.32%
|
|
|
New Square Capital LLC
|
Aug 05, 2025 Q2 2025 |
3,451
shares
|
$51,972
0.0% of portfolio
|
Q2 2025
Added 182.41%
|
|
|
Financial Avengers, Inc.
Oakland, CA |
Aug 12, 2025 Q2 2025 |
3,355
shares
|
$50,526
0.02% of portfolio
|
Q2 2025
Reduced 16.13%
|
|
|
Axa S.A.
Paris, I0 |
Aug 14, 2025 Q2 2025 |
2,862
shares
|
$43,101
0.0% of portfolio
|
Q2 2024
Added 24.74%
|
|
|
Evelyn Partners Investment Management LLP
London, |
Aug 12, 2025 Q2 2025 |
2,515
shares
|
$37,875
0.0% of portfolio
|
Q2 2025
Added 163.35%
|
|
|
Paradigm Asset Management CO LLC
|
Aug 06, 2025 Q2 2025 |
2,500
shares
|
$37,650
0.01% of portfolio
|
Q4 2024
Reduced 10.71%
|
|
|
Manchester Capital Management LLC
Manchester, VT |
Aug 12, 2025 Q2 2025 |
2,427
shares
|
$36,550
0.01% of portfolio
|
Q2 2025
Added 8.45%
|
|
|
Geneos Wealth Management Inc.
|
Aug 18, 2025 Q2 2025 |
2,208
shares
|
$33,252
0.0% of portfolio
|
Q2 2025
Added 17.26%
|
|
|
Addison Advisors LLC
|
Aug 07, 2025 Q2 2025 |
2,170
shares
|
$32,680
0.01% of portfolio
|
Q2 2025
Added 4.68%
|
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
2,144
shares
|
$32,288
0.01% of portfolio
|
Q3 2023
New holding
|
|
|
Rosenberg Matthew Hamilton
|
Jul 28, 2025 Q2 2025 |
2,104
shares
|
$31,686
0.01% of portfolio
|
Q3 2024
Added 34.79%
|
|
|
American Research & Management Co.
|
Oct 07, 2022 Q3 2022 |
2,000
shares
|
$30,120
0.01% of portfolio
|
Q1 2020
Added 3233.33%
|
|
|
Sunbelt Securities, Inc.
Houston, TX |
Aug 14, 2025 Q2 2025 |
1,987
shares
|
$29,924
0.0% of portfolio
|
Q2 2025
Added 427.06%
|
|
|
Twin Peaks Wealth Advisors, LLC
Burlingame, CA |
Aug 13, 2025 Q2 2025 |
1,927
shares
|
$29,020
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Private Capital Group, LLC
|
Jul 28, 2022 Q2 2022 |
1,896
shares
|
$28,553
0.02% of portfolio
|
Q2 2022
Added 1.66%
|
|
|
Smithfield Trust CO
Pittsburgh, PA |
Aug 08, 2025 Q2 2025 |
1,869
shares
|
$28,147
0.0% of portfolio
|
Q1 2025
Reduced 3.56%
|
|
|
Benjamin F. Edwards & Company, Inc.
St. Louis, MO |
Aug 12, 2024 Q2 2024 |
1,677
shares
|
$25,255
0.0% of portfolio
|
Q2 2024
Added 13.08%
|
|
|
Mai Capital Management
|
May 15, 2025 Q1 2025 |
1,657
shares
|
$24,954
0.0% of portfolio
|
Q1 2025
Added 3.76%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,577
shares
|
$23,749
0.0% of portfolio
|
Q2 2025
Reduced 4.66%
|
|
|
Whipplewood Advisors, LLC
Littleton, CO |
Jul 31, 2025 Q2 2025 |
1,551
shares
|
$23,358
0.01% of portfolio
|
Q2 2025
Added 8063.16%
|
|
|
Mondrian Investment Partners LTD
London, X0 |
May 13, 2025 Q1 2025 |
1,438
shares
|
$21,656
0.0% of portfolio
|
Q1 2025
Reduced 6.74%
|
|
|
Financial Perspectives, Inc
Minneapolis, MN |
Jul 29, 2025 Q2 2025 |
1,437
shares
|
$21,641
0.01% of portfolio
|
Q3 2021
Reduced 72.59%
|
|
|
Ancora Advisors, LLC
Cleveland, OH |
Aug 14, 2025 Q2 2025 |
1,413
shares
|
$21,279
0.0% of portfolio
|
Q2 2025
New holding
|